Patented joint health supplement with Phycox®, a natural source of phycocyanin, antioxidants, and Omega-3 Fatty Acids in a soft chew.
Phycox® Soft Chews
/Default.aspx?ID=5081&productid=PROD5177
Contains: | Phycocyanin, Glucosamine, Methylsulfonylmethane, Creatine Monohydrate, Antioxidants, plus additional ingredients |
---|---|
Size: | 60 ct, 120 ct |
Package Insert: | Download |
SDS: | Download |
VETORYL Capsules
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. In field studies and post-approval experience, the most common side effects reported were: anorexia, lethargy/depression, vomiting, diarrhea, elevated liver enzymes, elevated potassium with or without decreased sodium, elevated BUN, decreased Na/K ratio, hypoadrenocorticism, weakness, elevated creatinine, shaking, and renal insufficiency. In some cases, death has been reported as an outcome of these adverse events. VETORYL Capsules are not for use in dogs with primary hepatic or renal disease, or in pregnant dogs. Refer to the prescribing information for complete details. VETORYL Capsules Package Insert
FELIMAZOLE
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. The most commonly reported side effects are anorexia, vomiting, head/facial pruritus or edema, depression/lethargy, weight loss, anemia, elevated liver enzymes, skin lesions, elevated BUN, diarrhea, and thrombocytopenia. FELIMAZOLE Coated Tablets are not for use in pregnant or lactating queens, or cats with renal, hepatic, or hematological disorders. In some reported cases, the patients recovered after adverse signs were recognized, the drug was withdrawn, and veterinary care was applied. In some cases, death (or euthanasia) has been reported as an outcome of the adverse reactions listed above. Methimazole has anti-vitamin K activity and may induce bleeding diathesis without evidence of thrombocytopenia. Refer to the prescribing information for complete details. FELIMAZOLE Package Insert
ANIMAX OINTMENT
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. Hearing loss, with varying degrees of recovery, has been reported with the use of ANIMAX Ointment. If hearing dysfunction is noted during the course of treatment with ANIMAX Ointment, discontinue its use. SAP and SGPT (ALT) enzyme elevations, polydipsia and polyuria, vomiting, and diarrhea (occasionally bloody) have been observed following parenteral or systemic use of synthetic corticosteroids in dogs. Cushing’s syndrome has been reported in association with prolonged or repeated steroid therapy in dogs. Refer to the prescribing information for complete details. ANIMAX OINTMENT Package Insert
VETROPOLYCIN and VETROPOLYCIN HC
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. In field studies, the most common side effects reported were ocular itching, burning, or inflammation in animals sensitive to the product. Prolonged use may result in the overgrowth of nonsusceptible organisms including fungi. VETROPOLYCIN ONLY— Do not use as a pre-surgical ocular lubricant. VETROPOLYCIN HC ONLY— This product is not for use in animals with corneal ulcers, fungal infections, or viral infections. Patients should be monitored for signs of corticosteroid overdose. The safe use of this product has not been evaluated in pregnant animals. Refer to the prescribing information for VETROPOLYCIN and VETROPOLYCIN HC for complete details. VETROPOLYCIN Package Insert, VETROPOLYCIN HC Package Insert
OSPHOS
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. In field studies, the most common side effects reported were signs of discomfort or nervousness, colic, and/or pawing. OSPHOS should not be used in pregnant or lactating mares, or mares intended for breeding. Use of OSPHOS in patients with conditions affecting renal function or mineral or electrolyte homeostasis is not recommended. Refer to the prescribing information for complete details. OSPHOS Package Insert
Equidone Gel
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Side effects of using EQUIDONE Gel may be premature lactation and failure of passive transfer (FPT) of immunoglobulins to the foal. FPT can occur even when mares are not dripping milk. Refer to the prescribing information for complete details. Equidone Package Insert
MURICIN OINTMENT
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. MURICIN Ointment is not for ophthalmic use. Safety in pregnant or breeding animals has not been determined. Due to a potential hazard for nephrotoxicity due to polyethylene glycol content of the product base, exercise care in use for extensive deep lesions where absorption of large quantities of polyethylene glycol is possible. MURICIN OINTMENT Package Insert
ZYCORTAL SUSPENSION
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. As with all drugs, side effects may occur. In field studies the most common side effects reported were polyuria, polydipsia, depression/lethargy, inappropriate urination, alopecia, decreased appetite/anorexia, panting, vomiting, diarrhea, shaking/trembling, polyphagia, urinary tract infection, urinary tract incontinence and restlessness. ZYCORTAL Suspension should be used with caution in dogs with congestive heart disease, edema, severe renal disease or primary hepatic failure. Dogs presenting in Addisonian crisis must be rehydrated with appropriate intravenous therapy before starting treatment with ZYCORTAL suspension. Refer to the prescribing information for complete details. ZYCORTAL Suspension Package Insert
CARPROFEN CHEWABLE TABLETS
As with other NSAIDs, signs of carprofen intolerance may include appetite loss, vomiting and diarrhea, which could indicate side effects involving the digestive tract, liver or kidneys. Some of these side effects, in rare situations, may be serious, resulting in hospitalization, or even death. Pet owners should be advised to discontinue treatment if side effects occur and contact their veterinarian. Concomitant use of Putney Carprofen Chewable Tablets with other anti-inflammatory drugs, such as other NSAIDs or corticosteroids, should be avoided because of the potential increase of adverse reactions. Please see the Carprofen Chewable Tablets Package Insert and Carprofen Chewable Tablets Dog Owner Information Sheet for further safety and usage information
CARPROFEN CAPLETS
As with other NSAIDs, signs of Carprofen intolerance may include appetite loss, vomiting and diarrhea, which could indicate side effects involving the digestive tract, liver or kidneys. Some of these side effects, in rare situations, may be serious, resulting in hospitalization or even death. Pet owners should be advised to discontinue treatment if side effects occur and contact their veterinarian. Concomitant use of Putney Carprofen Caplets with other anti-inflammatory drugs, such as other NSAIDs or corticosteroids, should be avoided because of the potential increase of adverse reactions. Please see the Carprofen Caplets Package Insert and Carprofen Caplets Dog Owner Information Sheet for further safety and usage information.
CARPROFEN STERILE INJECTABLE SOLUTION
For subcutaneous use in dogs only. Serious adverse reactions associated with this drug class can occur without warning, and in rare situations, result in death. As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Appropriate laboratory tests to establish hematological and serum biochemical baseline data prior to, and periodically during, administration of any NSAID should be considered. Concomitant use of Carprofen Sterile Injectable Solution with other anti-inflammatory drugs, such as other NSAIDs or corticosteroids, should be avoided. Owners should be advised to discontinue Carprofen Sterile Injectable Solution therapy and contact their veterinarian immediately if signs of intolerance are observed. Please see the Carprofen Sterile Injectable Solution Package Insert for further safety and usage information.
ENROFLOXACIN FLAVORED TABLETS
In rare instances, use of this product in cats has been associated with Retinal Toxicity. Dosage should not exceed 5 mg/kg of body weight once daily in cats. Enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. Federal law prohibits the extralabel use of this drug in food-producing animals. Click here for full Enrofloxacin Flavored Tablets Package Insert.
CEFPODOXIME PROXETIL TABLETS
Cefpodoxime Proxetil should not be used in dogs that are hypersensitive to penicillin or cephalosporin. Safety in pregnant and lactating animals or breeding male dogs has not been established. See package insert for complete indications, side effects, contraindications and other important product information. Click here for full Cefpodoxime Proxetil Tablets Package Insert.
Dexmedesed® (dexmedetomidine hydrochloride)
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use Dexmedesed® in dogs or cats with cardiovascular disease, respiratory disorders, liver or kidney diseases, or in conditions of shock, severe debilitation, or stress due to extreme heat, cold or fatigue. As with all alpha2-adrenoceptor agonists, the potential for isolated cases of hypersensitivity, including excitation, exists. The following adverse reactions have been reported: death, cardiac arrest, bradycardia, apnea, vomiting, may occur with use. The use of Dexmedesed® as a preanesthetic in dogs and cats significantly reduces the amount of induction and maintenance anesthetic requirements. In cats, severe dyspnea and respiratory crackles diagnosed as acute pulmonary edema could develop. Refer to Dexmedesed® Package Insert for additional safety information.
Tilzolan® (tiletamine HCl and Zolazepam HCl)
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Tilzolan® should not be used in dogs and cats with pancreatic disease, renal pathology or impairment of renal function, or severe cardiac or pulmonary dysfunction. Do not use at any stage of pregnancy or for Caesarean section. Do not use phenothiazine-derivative drugs concomitantly with Tilzolan® as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of Tilzolan®. Copious salivation may occur during Tilzolan® anesthesia and may be controlled by giving atropine sulfate, USP as a concurrent medication. Vomiting upon emergence, involuntary muscle twitching and cardiac arrest have occasionally been reported with Tilzolan®. Please see Tilzolan® Package Insert for complete indications, side effects, contraindications and other important product information.
MELOXICAM SOLUTION FOR INJECTION
Warning: Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. See Contraindications, Warnings, and Precautions for detailed information. |
Important Safety Information for Cats: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use meloxicam in cats with pre-existing renal dysfunction. Do not follow the single, one-time dose of meloxicam with any other NSAID. Do not use IV in cats. When administering any NSAID, appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to use in dogs and cats. All cats should undergo a thorough history and physical examination before administering meloxicam. Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. Owner should be advised to observe their cats for signs of potential drug toxicity. Refer to Meloxicam Solution for Injection package insert for additional safety information.
Important Safety Information for Dogs: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Dogs with known hypersensitivity to meloxicam should not receive Meloxicam Solution for Injection. All dogs should undergo a thorough history and physical examination before administering any NSAID. Appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to, and periodically during use of any NSAID in dogs. Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. A field study involving 224 dogs was conducted. Based on the results of this study, GI abnormalities (vomiting, soft stools, diarrhea, and inappetance) were the most common adverse reactions associated with the administration of meloxicam. Owner should be advised to observe their dogs for signs of potential drug toxicity. Refer to Meloxicam Solution for Injection package insert for additional safety information.
Ketamine Hydrochloride Injection, USP
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Ketamine Hydrochloride Injection, USP is contraindicated in cats and subhuman primates suffering from renal or hepatic insufficiency. To reduce the incidence of emergence reactions, animals should not be stimulated by sound or handling during the recovery period. Apnea, respiratory arrest, cardiac arrest and death have occasionally been reported with ketamine used alone, and more frequently when used in conjunction with sedatives or other anesthetics. Respiratory depression may occur following administration of high doses of Ketamine Hydrochloride Injection, USP. If at any time respiration becomes excessively depressed and the animal becomes cyanotic, resuscitative measures should be instituted promptly. In the cat, myoclonic jerking and/or mild tonic convulsions can be controlled by ultrashort-acting barbiturates which should be given to effect. The barbiturates should be administered intravenously at a dose level of one-sixth to one-fourth the usual dose for the product being used. See Ketamine Hydrochloride Injection, USP Package Insert for complete indications, side effects, contraindications and other important product information.
Amoxicillin Trihydrate and Clavulanate Potassium Tablets
As with all drugs, side effects may occur. Amoxicillin Trihydrate and Clavulanate Potassium Tablets contain a semisynthetic penicillin (amoxicillin) and have the potential for producing allergic reactions. This product should not be used in animals with a history of an allergic reaction to any of the penicillins or cephalosporins. If an allergic reaction occurs, administer epinephrine and/or steroids. Refer to the prescribing information for complete details. Amoxicillin Trihydrate and Clavulanate Potassium Tablets Package Insert
Carprovet Flavored Tablets
As with other NSAIDs, signs of Carprofen intolerance may include appetite loss, vomiting and diarrhea, which could indicate side effects involving the digestive tract, liver or kidneys. Some of these side effects, in rare situations, may be serious, resulting in hospitalization or even death. Pet owners should be advised to discontinue treatment if side effects occur and contact their veterinarian. Concomitant use of Putney Carprovet Flavored Tablets with other anti-inflammatory drugs, such as other NSAIDs or corticosteroids, should be avoided because of the potential increase of adverse reactions. Please see the Carprovet Flavored Tablets Package Insert and Carprovet Flavored Tablets Dog Owner Information Sheet for further safety and usage information.
Navigation